Log in

NASDAQ:ALNYAlnylam Pharmaceuticals SEC Filings & 10K Form

$162.25
+3.51 (+2.21 %)
(As of 07/10/2020 04:00 PM ET)
Add
Compare
Today's Range
$157.30
Now: $162.25
$162.33
50-Day Range
$125.39
MA: $141.28
$160.42
52-Week Range
$69.11
Now: $162.25
$164.09
Volume748,700 shs
Average Volume1.01 million shs
Market Capitalization$18.72 billion
P/E RatioN/A
Dividend YieldN/A
Beta1.86

SEC Filings

Alnylam Pharmaceuticals (NASDAQ:ALNY) SEC Filings

DateFilerForm TypeView
07/09/2020
3:02 PM
Alnylam Pharmaceuticals (Issuer)
Greene Barry E (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
07/06/2020
3:52 PM
Alnylam Pharmaceuticals (Issuer)
Ausiello Dennis A (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
07/06/2020
3:52 PM
Alnylam Pharmaceuticals (Issuer)
Fanucci Marsha (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
07/06/2020
3:51 PM
Alnylam Pharmaceuticals (Issuer)
PAUL STEVEN M (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
07/06/2020
3:51 PM
Alnylam Pharmaceuticals (Issuer)
SHARP PHILLIP A (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
07/06/2020
3:50 PM
Alnylam Pharmaceuticals (Issuer)
SCHULMAN AMY W (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
07/06/2020
3:50 PM
Alnylam Pharmaceuticals (Issuer)
Reitan Colleen F (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
07/06/2020
3:49 PM
Alnylam Pharmaceuticals (Issuer)
PYOTT DAVID E I (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/24/2020
3:02 PM
Alnylam Pharmaceuticals (Issuer)
Vaishnaw Akshay (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/05/2020
4:12 PM
Alnylam Pharmaceuticals (Filer)
Form S-3ASR
05/06/2020
7:10 AM
Alnylam Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/22/2020
3:07 PM
Alnylam Pharmaceuticals (Issuer)
KEATING LAURIE (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/22/2020
3:06 PM
Alnylam Pharmaceuticals (Issuer)
Vaishnaw Akshay (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/13/2020
3:22 PM
Alnylam Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/06/2020
7:51 AM
Alnylam Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/23/2020
7:56 PM
Alnylam Pharmaceuticals (Filer)
Form DEFA14A
03/04/2020
3:35 PM
Alnylam Pharmaceuticals (Issuer)
BRANDICOURT OLIVIER (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/21/2020
3:02 PM
Alnylam Pharmaceuticals (Issuer)
MARAGANORE JOHN (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/13/2020
7:50 AM
Alnylam Pharmaceuticals (Filer)
Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans  
02/13/2020
7:29 AM
Alnylam Pharmaceuticals (Filer)
Form 10-K
Annual report pursuant to Section 13 or 15(d)  
02/12/2020
6:23 AM
Alnylam Pharmaceuticals (Subject)
VANGUARD SPECIALIZED FUNDS (Filed by)
Form SC 13G/A
02/06/2020
7:28 AM
Alnylam Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/03/2020
8:15 AM
Alnylam Pharmaceuticals (Subject)
BAILLIE GIFFORD & CO (Filed by)
Form SC 13G
01/28/2020
11:05 AM
Alnylam Pharmaceuticals (Subject)
WELLINGTON MANAGEMENT GROUP LLP (Filed by)
Form SC 13G/A
01/13/2020
5:13 AM
Alnylam Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/26/2019
3:04 PM
Alnylam Pharmaceuticals (Issuer)
Vaishnaw Akshay (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/26/2019
3:04 PM
Alnylam Pharmaceuticals (Issuer)
MARAGANORE JOHN (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/26/2019
3:03 PM
Alnylam Pharmaceuticals (Issuer)
KEATING LAURIE (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/26/2019
3:03 PM
Alnylam Pharmaceuticals (Issuer)
Greenstreet Yvonne (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/26/2019
3:02 PM
Alnylam Pharmaceuticals (Issuer)
Greene Barry E (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/13/2019
3:25 PM
Alnylam Pharmaceuticals (Issuer)
Greenstreet Yvonne (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/20/2019
3:46 PM
Alnylam Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/20/2019
3:17 PM
Alnylam Pharmaceuticals (Issuer)
SHARP PHILLIP A (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
10/31/2019
3:03 PM
Alnylam Pharmaceuticals (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
10/31/2019
7:10 AM
Alnylam Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/24/2019
3:04 PM
Alnylam Pharmaceuticals (Issuer)
Greene Barry E (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
10/16/2019
3:06 PM
Alnylam Pharmaceuticals (Issuer)
MARAGANORE JOHN (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/13/2019
3:09 PM
Alnylam Pharmaceuticals (Issuer)
Poulton Jeffrey V. (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
08/07/2019
3:17 PM
Alnylam Pharmaceuticals (Issuer)
Greenstreet Yvonne (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/07/2019
3:17 PM
Alnylam Pharmaceuticals (Issuer)
KEATING LAURIE (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/07/2019
3:16 PM
Alnylam Pharmaceuticals (Issuer)
Greene Barry E (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/07/2019
3:16 PM
Alnylam Pharmaceuticals (Issuer)
MARAGANORE JOHN (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/06/2019
3:19 PM
Alnylam Pharmaceuticals (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
08/06/2019
7:15 AM
Alnylam Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
07/11/2019
3:15 PM
Alnylam Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
07/05/2019
9:07 AM
Alnylam Pharmaceuticals (Filer)
Form CT ORDER
07/02/2019
3:05 PM
Alnylam Pharmaceuticals (Issuer)
Fanucci Marsha (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
07/02/2019
3:03 PM
Alnylam Pharmaceuticals (Issuer)
Ausiello Dennis A (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/07/2019
3:04 PM
Alnylam Pharmaceuticals (Issuer)
MARAGANORE JOHN (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/07/2019
3:04 PM
Alnylam Pharmaceuticals (Issuer)
Greenstreet Yvonne (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/07/2019
3:04 PM
Alnylam Pharmaceuticals (Issuer)
Greene Barry E (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/07/2019
3:03 PM
Alnylam Pharmaceuticals (Issuer)
Vaishnaw Akshay (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/07/2019
3:03 PM
Alnylam Pharmaceuticals (Issuer)
KEATING LAURIE (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/21/2019
3:31 PM
Alnylam Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/03/2019
3:02 PM
Alnylam Pharmaceuticals (Subject)
Sanofi (Filed by)
Form SC 13G/A
05/02/2019
8:59 AM
Alnylam Pharmaceuticals (Filer)
Form CT ORDER
05/02/2019
8:58 AM
Alnylam Pharmaceuticals (Filer)
Form CT ORDER
05/01/2019
7:45 AM
Alnylam Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/26/2019
3:32 PM
Alnylam Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/17/2019
3:05 PM
Alnylam Pharmaceuticals (Issuer)
SHARP PHILIP A (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/10/2019
5:05 AM
Alnylam Pharmaceuticals (Filer)
Form DEFA14A
04/09/2019
3:43 PM
Alnylam Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/08/2019
3:24 PM
Alnylam Pharmaceuticals (Filer)
Form DEFA14A
03/21/2019
6:30 AM
Alnylam Pharmaceuticals (Filer)
Form DEF 14A
03/11/2019
4:07 PM
Alnylam Pharmaceuticals (Filer)
Form PRE 14A
03/01/2019
5:11 PM
Alnylam Pharmaceuticals (Issuer)
Greenstreet Yvonne (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/01/2019
5:10 PM
Alnylam Pharmaceuticals (Issuer)
Greene Barry E (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/01/2019
5:10 PM
Alnylam Pharmaceuticals (Issuer)
Soni Manmeet Singh (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/01/2019
5:10 PM
Alnylam Pharmaceuticals (Issuer)
Vaishnaw Akshay (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/01/2019
5:09 PM
Alnylam Pharmaceuticals (Issuer)
KEATING LAURIE (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/01/2019
5:09 PM
Alnylam Pharmaceuticals (Issuer)
MARAGANORE JOHN (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/14/2019
12:04 PM
Alnylam Pharmaceuticals (Subject)
DODGE & COX (Filed by)
Form SC 13G/A
02/11/2019
11:46 AM
Alnylam Pharmaceuticals (Subject)
VANGUARD GROUP INC (Filed by)
Form SC 13G/A
02/07/2019
3:15 PM
Alnylam Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/31/2019
2:09 PM
Alnylam Pharmaceuticals (Subject)
VANGUARD SPECIALIZED FUNDS (Filed by)
Form SC 13G/A
01/22/2019
2:13 PM
Alnylam Pharmaceuticals (Issuer)
Sanofi (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/15/2019
4:19 PM
Alnylam Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/15/2019
4:14 PM
Alnylam Pharmaceuticals (Filer)
Form 424B5
01/14/2019
3:41 PM
Alnylam Pharmaceuticals (Filer)
Form 424B5
01/11/2019
3:07 PM
Alnylam Pharmaceuticals (Issuer)
HAMBURG MARGARET A (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/11/2019
3:06 PM
Alnylam Pharmaceuticals (Issuer)
HAMBURG MARGARET A (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
01/07/2019
7:11 AM
Alnylam Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/10/2018
4:19 PM
Alnylam Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/26/2018
3:11 PM
Alnylam Pharmaceuticals (Issuer)
MARAGANORE JOHN (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/07/2018
3:32 PM
Alnylam Pharmaceuticals (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
11/07/2018
7:16 AM
Alnylam Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/10/2018
3:31 PM
Alnylam Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/28/2018
3:59 PM
Alnylam Pharmaceuticals (Issuer)
KEATING LAURIE (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
09/28/2018
3:58 PM
Alnylam Pharmaceuticals (Issuer)
Greenstreet Yvonne (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
09/28/2018
3:57 PM
Alnylam Pharmaceuticals (Issuer)
Vaishnaw Akshay (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
09/28/2018
3:56 PM
Alnylam Pharmaceuticals (Issuer)
MARAGANORE JOHN (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
09/28/2018
3:55 PM
Alnylam Pharmaceuticals (Issuer)
Mason Michael (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
09/28/2018
3:54 PM
Alnylam Pharmaceuticals (Issuer)
Greene Barry E (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
09/12/2018
4:16 PM
Alnylam Pharmaceuticals (Filer)
Form CT ORDER
09/04/2018
3:15 PM
Alnylam Pharmaceuticals (Issuer)
Greenstreet Yvonne (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/23/2018
3:15 PM
Alnylam Pharmaceuticals (Issuer)
MARAGANORE JOHN (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/23/2018
3:15 PM
Alnylam Pharmaceuticals (Issuer)
Greene Barry E (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/23/2018
3:15 PM
Alnylam Pharmaceuticals (Issuer)
Vaishnaw Akshay (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/23/2018
3:14 PM
Alnylam Pharmaceuticals (Issuer)
KEATING LAURIE (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/23/2018
3:13 PM
Alnylam Pharmaceuticals (Issuer)
Mason Michael (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
This page was last updated on 7/11/2020 by MarketBeat.com Staff

30 Days of MarketBeat All Access for $1.00

Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools:

  • Best-in-Class Portfolio Monitoring

    View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.

  • Stock Ideas and Recommendations

    Get daily stock ideas top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.

  • Advanced Stock Screeners and Research Tools

    Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your Risk-Free Trial Subscription Here

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.